Haemonetics (HAE) Receivables - Other (2012 - 2018)
Haemonetics (HAE) posted Receivables - Other of $5.0 million for Q1 2018, little changed on a QoQ basis from $5.0 million in Q4 2017, and up 72.41% year-over-year from $2.9 million in Q1 2017.
Analysis
Haemonetics (HAE) Receivables - Other (2012 - 2018) Analysis & Trends
Haemonetics has reported Receivables - Other for 3 years, with the latest figure at $5.0 million in Q1 2018.
- On a quarterly basis, Receivables - Other rose 72.41% year-over-year to $5.0 million in Q1 2018; TTM through Mar 2018 was $5.0 million, a 72.41% increase from a year earlier, with the FY2018 full-year figure at $5.0 million, up 72.41% from the prior year.
- Receivables - Other was $5.0 million for Q1 2018 at Haemonetics, roughly flat from $5.0 million in the prior quarter.
- The five-year high for Receivables - Other was $5.0 million in Q4 2017, with the low at $2.1 million in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.58 Bn | 4.36 Bn | 202.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 5.00 Mn |
| Dec 30, 2017 | 5.00 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Jul 1, 2017 | 2.90 Mn |
| Apr 1, 2017 | 2.90 Mn |
| Dec 29, 2012 | 8.20 Mn |
| Sep 29, 2012 | 100,000.00 |
| Mar 31, 2012 | 3.20 Mn |